Compumedics Ltd - Asset Resilience Ratio
Compumedics Ltd (CMP) has an Asset Resilience Ratio of 16.97% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Compumedics Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2022)
This chart shows how Compumedics Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Compumedics Ltd (CMP) total assets.
Liquid Assets Composition Over Time
This chart breaks down Compumedics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Compumedics Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$7.08 Million | 16.97% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$7.08 Million | 16.97% |
Asset Resilience Insights
- Good Liquidity Position: Compumedics Ltd maintains a healthy 16.97% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Compumedics Ltd Industry Peers by Asset Resilience Ratio
Compare Compumedics Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
|
Hi-Clearance
TWO:1788 |
Medical Devices | 2.55% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 15.99% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Compumedics Ltd (2016–2022)
The table below shows the annual Asset Resilience Ratio data for Compumedics Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-06-30 | 16.97% | AU$7.08 Million ≈ $5.01 Million |
AU$41.71 Million ≈ $29.51 Million |
+5.08pp |
| 2019-06-30 | 11.90% | AU$4.60 Million ≈ $3.25 Million |
AU$38.66 Million ≈ $27.36 Million |
+0.62pp |
| 2018-06-30 | 11.27% | AU$3.91 Million ≈ $2.76 Million |
AU$34.65 Million ≈ $24.52 Million |
-2.76pp |
| 2017-06-30 | 14.03% | AU$4.10 Million ≈ $2.90 Million |
AU$29.23 Million ≈ $20.68 Million |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$26.12 Million ≈ $18.48 Million |
-- |
About Compumedics Ltd
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST… Read more